Preoperative albumin treatment to prevent kidney injury in young heart surgery patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the impact of administering albumin to pediatric patients with low albumin levels before undergoing cardiac surgery. The goal is to determine if this treatment can reduce inflammation and prevent acute kidney injury that may occur after cardiopulmonary bypass. The study focuses on children under 7 years of age who meet specific criteria regarding their serum albumin levels. By comparing outcomes in patients receiving albumin versus those receiving crystalloid solutions, the researchers aim to identify effective preoperative interventions.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Pediatric patients under 7 years of age undergoing cardiac surgery with cardiopulmonary bypass
* Preoperative serum albumin level of 4.0 g/dL or lower

Exclusion Criteria:

* abnormal preoperative creatinine level
* history of dialysis
* liver dysfunction
* diabetes
* history of hypersensitivity to albumin
* coagulation disorders

Where it's running

• Seoul National University Hospital
  Seoul, Seoul, South Korea Recruiting

Study contacts

• Study coordinator: Ji-Hyun Lee
• Email: muslab6@snu.ac.kr
• Phone: 82-2-2072-3661

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Remote Ischemic Preconditioning at Different Times After Heart Valve Surgery

  This study tests whether applying brief, controlled blood-flow restrictions to a limb at different times after heart valve surgery can help protect organs and reduce complications like kidney injury.

  Recruiting Fujian Medical University Union Hospital · Fuzhou, Fujian · NCT07888634

• Clinical decision support to help consider SGLT2 inhibitors after AKI in type 2 diabetes

  This pilot test checks if a CDS message given to clinicians can help decide whether to consider SGLT2 inhibitors for adults with type 2 diabetes who recently had acute kidney injury.

  Recruiting University of Minnesota · Minneapolis, Minnesota · NCT07868666

• Biomarkers to predict CSA-AKI risk before heart surgery

  This study tests new biomarkers to see if they can predict CSA-AKI risk in adults undergoing cardiovascular surgery.

  Recruiting China National Center for Cardiovascular Diseases · Beijing, Beijing Municipality · NCT07811570

• Reducing Endotoxin Burden in Septic Shock Patients on CRRT with the oXiris Filter

  This trial tests whether using the oXiris hemofilter during continuous kidney replacement helps lower endotoxin levels in adults with septic shock who need CRRT.

  Recruiting Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · Guangzhou, Guangdong · NCT07807410

• Precision TOF-Guided Sugammadex for Early Extubation in Pediatric Minimally Invasive Cardiac Surgery

  This study tests whether using TOF monitoring to guide sugammadex reversal helps bring children off ventilators earlier after minimally invasive heart surgery.

  Recruiting National Children's Hospital, Vietnam · Hanoi · NCT07798011

• Perioperative GFR Monitoring to Predict CSA-AKI and CA-AKI

  This study tests whether perioperative transcutaneous fluorescence GFR measurements can predict CSA-AKI or CA-AKI in adults undergoing cardiovascular procedures or iodine contrast exposure.

  Recruiting China National Center for Cardiovascular Diseases · Beijing, Beijing Municipality · NCT07749417

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.